Seek emergency medical care immediately if you experience severe, sudden back pain with nausea and vomiting, as this may indicate pancreatitis
CagriSema, as of mid-2026, has completed its Phase 3a REDEFINE program but is not approved by the FDA, the EMA, or any other regulator, and its benefitrisk profile is still under review
My endocrinologist suggested trying retatrutide because of the added glucagon effect for better metabolism
Meanwhile, Eli Lilly is juggling lawsuits filed by Trulicity patients who allege they suffered severe, unexpected complications after taking Trulicity
Glucagon gene expression in vertebrate brain
International shipping may take longer due to customs processing